FLAM
ELDN icon

First Light Asset Management’s Eledon Pharmaceuticals ELDN Stock Holding History

First Light Asset Management’s Portfolio ELDN Stock Details ELDN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-2,600,498
Closed -$7.05M – 42
2025
Q2 		$7.05M Buy
2,600,498
+271,730
+12% +$815K 0.91% 27
2025
Q1 		$7.89M Hold
2,328,768
– – 0.9% 25
2024
Q4 		$9.59M Buy
+2,328,768
New +$9.18M 0.92% 29

Other funds holding ELDN

BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
ZP
Zimmer Partners New York $4.34B AUM 22.78% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $767M AUM 119.71% 1-Year Est. Return
Ensign Peak Advisors
Ensign Peak Advisors Salt Lake City, Utah $60.8B AUM 42.06% 1-Year Est. Return

First Light Asset Management's ELDN Position: Q3 2025 in Review

First Light Asset Management sold out of Eledon Pharmaceuticals (ELDN) in Q3 2025, closing a stake of 2,600,498 shares — an estimated $7.05M sold.

First Light Asset Management first reported a position in ELDN in Q4 2024 and held it in 3 quarters. The position peaked at $9.59M in Q4 2024. 83 funds tracked by Wall St. Rank hold ELDN as of Q3 2025.

  • First Light Asset Management reported no remaining Eledon Pharmaceuticals position as of Q3 2025 after selling out during the quarter.
  • First Light Asset Management sold 2,600,498 Eledon Pharmaceuticals shares in Q3 2025, an estimated $7.05M.
  • First Light Asset Management first reported a position in Eledon Pharmaceuticals in Q4 2024 and held it in 3 quarters.
  • First Light Asset Management's Eledon Pharmaceuticals position peaked at $9.59M in Q4 2024.
  • 83 funds tracked by Wall St. Rank held Eledon Pharmaceuticals as of Q3 2025.

Based on First Light Asset Management's 13F filing for Q3 2025, filed 14 Nov 2025.